Moderna (MRNA) has had the highest return since June 4, 2026 by a US stock with a market cap of $50B+, returning 348.8%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 348.84% |
Natera (NTRA) | 93.64% |
Veeva Systems Inc Class A (VEEV) | 71.15% |
Marathon Petroleum (MPC) | 69.49% |
Valero Energy (VLO) | 56.81% |
Phillips 66 (PSX) | 55.9% |
Crowdstrike (CRWD) | 48.61% |
Regeneron Pharmaceuticals (REGN) | 47.91% |
Thermo Fisher Scientific (TMO) | 44.82% |
Accenture (ACN) | 43.42% |
Cheniere Energy (LNG) | 40.93% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 39.6% |
Thomson Reuters Corporation Common Shares (TRI) | 37.63% |
Palo Alto Networks (PANW) | 35.58% |
Amgen (AMGN) | 35.52% |
Travelers Companies (TRV) | 35.51% |
Becton Dickinson and (BDX) | 34.64% |
AbbVie (ABBV) | 34.3% |
Arthur J Gallagher (AJG) | 33.88% |
Mastercard (MA) | 33.47% |
McKesson (MCK) | 32.48% |
Gilead Sciences (GILD) | 32.32% |
ConocoPhillips (COP) | 31.43% |
Equinor ASA ADR (EQNR) | 31.16% |
Visa Inc Class A (V) | 30.8% |